Tianjin Dexiang Biotechnology Co., Ltd. (hereinafter referred to as "Dexbio") was established on December 16, 2011. It is a key investment attraction project in the west area of Tianjin Binhai New Area Development Zone, with a registered capital of 23.58 million RMB and a total project investment of 83 million RMB. , is a high-tech enterprise engaged in R&D, production and sales of blood transfusion detection products.
Legend has it that in ancient times, there were ten suns in the sky, scorching the earth. Seeing that the world was about to perish, a warrior named Hou Yi shot nine suns to death with arrow. Only the last sun remained, seriously injured, fell to the world, and the world fell into darkness. The only remedy is to exchange the sunbird's nirvana for the rebirth of the sun.
Corporate Vision: To become a leading enterprise in the field of blood transfusion testing
Corporate Mission: Committed to the development and application of blood transfusion detection technology to make detection more accurate, convenient and intelligent.
Corporate Philosophy: To be perfect
Work Style: Results, Simple, Exquisite, Fast
Work Concept: Joint entrepreneurship, Achievement sharing
Copyright © 2011 - 2017 Dexiang Biotech Co.,LTD
备案号:津ICP备14003466号-1 互联网药品信息服务备案号:2024010012 ICP Number 12019002000261